Ten years of a pediatric living donor liver transplantation program in Brazil

Table 2 Post-transplant complications in the two periods, n (%)

	First period (2013-2017), n = 25	Second period (2018-2023), n = 48	P value
Acute rejection	6 (24)	2 (4.2)	0.01
Chronic rejection	1 (4)	0 (0)	0.34
CMV infection	20 (80)	28 (58.3)	0.07
EBV infection	19 (76)	20 (41.7)	0.007
PTLD	1 (4)	2 (4.2)	1
HAT	4 (16)	3 (6.3)	0.22
Portal vein graft	3 (12)	12 (25)	0.23
PVT	4 (16)	7 (14.6)	1
PV stenosis	3 (12)	8 (17.6)	0.73
HV stenosis	2 (8)	0 (0)	0.11
Bile leak	6 (24)	21 (43.8)	0.12
Biliary strictures	10 (40)	7 (14.6)	0.02
Reoperation	7 (28)	15 (31.3)	1
Retransplant	2 (8)	0 (0)	0.11
Death	4 (16)	4 (8.3)
Clavien-Dindo classification of complications1			0.34
I	0	6 (12.5)
II	12 (48)	17 (35.4)
IIIA	1 (4)	0
IIIB	7 (28)	11 (29)
IVA	2 (8)	8 (16.7)
IVB	1 (4)	2 (4.2)
V	2 (8)	4 (8.3)

¹Considered until hospital discharge.

CMV: Cytomegalovirus; EBV: Epstein-barr virus; PTLD: Post-transplant lymphoproliferative disease; HAT: Hepatic artery thrombosis; PVT: Portal vein thrombosis; PV: Portal vein; HV: Hepatic vein.